Chronic Pancreatitis II: Collaborative Care
Acute Pancreatitis II: Clinical Manifestations and Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 9, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Valeria Tonini1, Manuel Zanni2
1Department of Medical and Surgical Sciences, University of Bologna, Bologna 40138, Emilia-Romagna, Italy. valeria.tonini@unibo.it.
Pancreatic cancer remains a deadly disease with poor outcomes. Recent advancements focus on early detection, molecular understanding, new therapies, and AI to improve patient survival and quality of life.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: